Kg. Perry et al., INCIDENCE OF ADVERSE CARDIOPULMONARY EFFECTS WITH LOW-DOSE CONTINUOUSTERBUTALINE INFUSION, American journal of obstetrics and gynecology, 173(4), 1995, pp. 1273-1277
OBJECTIVE: Our purpose was to determine the incidence of adverse cardi
ovascular effects of terbutaline sulfate when administered as a contin
uous subcutaneous infusion in women with arrested pretrem labor. STUDY
DESIGN: Over a 6-year period records from 8709 women prescribed this
therapy for preterm labor that had preivously been arrested with other
intravenous tocolytics were reviewed. These women were assessed daily
for cardiovascular complaints and tolerance of the medication, while
either in the hospital or at the home (by telephone). The main outcome
s studied were the occurrence of pulmonary edema, sustained cardiac ar
rhythmias, chest pain, or myocardial ischemia. Any maternal death rega
rdless of cause was also reviewed. RESULTS: Of the 8709 subjects, 47 (
0.54%) had one or more cardiopulmonary problems. Pulmonary edema devel
oped in 28 patients (0.32%) while receiving continuous subcutaneous in
fusion of terbutaline, 5 at home and 23 in the hospital. Of the total,
17 women were being treated concurrently with large amounts of intrav
enous fluids and one to three other tocolytic agents. In the 11 remain
ing subjects, 4 were diagnosed with pregnancy-induced hypertension and
/or multiple gestation. Nineteen patients experienced other adverse ca
rdiovascular effects, including electrocardiogram changes, irregular h
eart rate, chest pain, or shortness of breath. CONCLUSIONS: Continuous
terbutaline infusion for women with stabilized preterm labor is assoc
iated with much fewer adverse effects than previous literature regardi
ng intravenous beta-adrenergic agonist therapy would suggest.